New Gene Therapy for Sickle Cell Disease Considered Safe, FDA
WEDNESDAY, Nov. 1, 2023 -- A new gene therapy for sickle cell disease was deemed safe by a U.S. Food and Drug Administration advisory panel on Tuesday, paving the way for full approval by early December.
The FDA had already decided that the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Food and Drug Administration (FDA) | Gene Therapy | Genetics | Pharmaceuticals | Sickle Cell Anemia